Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. (Q52937783)

9 May 2018

title

Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. (English)

1 reference

9 May 2018

1 reference

1 reference

Heinrich Schulte-Baukloh

1

1 reference

9 May 2018

Catarina Weiss

2

1 reference

9 May 2018

Thomas Stolze

3

1 reference

9 May 2018

Burkard Stürzebecher

4

1 reference

9 May 2018

Helmut H Knispel

5

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 July 2005

1 reference

9 May 2018

published in

Urology

1 reference

9 May 2018

volume

66

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

82-87

1 reference

9 May 2018

Effects of Botulinum a Toxin on Detrusor-Sphincter Dyssynergia in Spinal Cord Injury Patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Botulinum A Toxin Urethral Injection for the Treatment of Lower Urinary Tract Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Prevalence and burden of overactive bladder in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

A long-term study of the persistence of the urodynamic characteristics of the unstable bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Is the treatment of urgency incontinence a placebo response? Results of a five-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Development of a symptom severity index and a symptom impact index for stress incontinence in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Antibacterial mesh sling: a prospective outcome analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.036

10.1016/J.UROLOGY.2005.01.036

7 January 2021

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018